Tuesday, 02 January 2024 12:17 GMT
عربي


               US          Europe          Arab          Asia          Africa    
|      Politics          Economy     Oil&Energy         
                 Entertainment          Sport
Destiny Pharma Looking To Move On To Phase III With XF-73 Nasal Gel

Destiny Pharma Looking To Move On To Phase III With XF-73 Nasal Gel


2023-03-27 02:05:45
(MENAFN- News Direct) London, UK | March 27, 2023 08:31 AM Eastern Daylight Time


--p
< />

Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) chief executive Neil Clark speaks to Thomas Warner from Proactive after publishing research about the company's new nasal gel, called XF-73, in the US journal 'Infection Control & Hospital Epidemiology'.


Clark explains more about the benefits of the gel and how it works, and confirms that the plan is to find a partner to help fund a phase III study.


MENAFN27032023005728012573ID1105874875



News Direct

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Tags

Label

Comments

No comment

Category

Date
Search